Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Am J Forensic Med Pathol ; 17(2): 109-11, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8727284

ABSTRACT

A blood sample drawn by a blind stick through the chest was collected for toxicologic examination in a suspected natural death. Drug screen results on the blood sample indicated a combined overdose of alcohol and amitriptyline. An autopsy was later performed and a peripheral blood sample was drawn. A drug screen of this sample showed the presence of therapeutic quantities of amitriptyline and a trace of alcohol. Cytologic examination of the blind-stick sample showed the presence of columnar cells and food debris, confirming that the sample was contaminated either by stomach contents or gastric aspirate during the collection procedure. We strongly encourage all agencies to refrain from the use of blind-stick sample collection for toxicologic specimens.


Subject(s)
Autopsy/methods , Blood Chemical Analysis/methods , Gastrointestinal Contents/chemistry , Phlebotomy/methods , Ethanol/blood , Ethanol/urine , Female , Humans , Middle Aged , Pharmaceutical Preparations/analysis , Reproducibility of Results , Specimen Handling
3.
JAMA ; 244(18): 2071-3, 1980 Nov 07.
Article in English | MEDLINE | ID: mdl-6159488

ABSTRACT

Prostatic acid phosphatase values in 98 patients with prostatic carcinoma were measured by a commercial radioimmunoassay (RIA) and by enzymatic assay. Forty-three carcinomas were staged by rigorous pathological criteria. Patients (N = 129) with benign prostatic hyperplasia were the control group. At 94% specificity, sensitivities of the RIA vs the enzymatic assay for clinically staged patients were as follows: stage A, 22% vs 6%; B, 29% vs 10%; C, 52% vs 38%; and D, 87% vs 80%. However, none of the seven patients with pathological stage A and B disease had a positive test result, and we suggest that variability in staging criteria accounts for the discrepant sensitivity claims reported. Prostatic acid phosphatase RIA should not be used for screening but as an adjunct for staging known prostatic carcinoma.


Subject(s)
Acid Phosphatase/metabolism , Clinical Enzyme Tests , Prostate/enzymology , Prostatic Neoplasms/diagnosis , Radioimmunoassay , Humans , Male , Neoplasm Staging , Prostatic Hyperplasia/diagnosis , Prostatic Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...